← Eichor
Condition: Nasopharyngeal Cancinoma Npc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Nasopharyngeal Cancinoma Npc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 · 6 location(s) · Sun Yat-sen University · NCT07201337LDRT Combined With Toripalimab and Chemotherapy for Recurrent/Metastatic NPC
Phase 2 · 2 location(s) · Sun Yat-sen University · NCT07325539Nab-TPC vs GP Combined With Camrelizumab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06669611A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Phase 1/Phase 2 · 20 location(s) · Hummingbird Bioscience · NCT05910827Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metast
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07705243IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features
Phase N/A · 1 location(s) · Qiaojuan Guo · NCT07376603LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
Phase 2 · 8 location(s) · Hunan Cancer Hospital · NCT06788002Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Phase 2 · 1 location(s) · Fudan University · NCT07067268Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasophary
Phase 2 · 4 location(s) · Sun Yat-sen University · NCT07528183SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After
Phase 2 · 2 location(s) · The First Affiliated Hospital of Xiamen University · NCT06676722Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic H
Phase 1 · 1 location(s) · West China Hospital · NCT07625423Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy
Phase N/A · 1 location(s) · Cheng-En Hsieh · NCT07232680EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Phase 1/Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06802835Adaptive Immunotherapy for Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT07154069A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT06829147Becotatug Vedotin for LA-NPC With a Suboptimal Response to Induction Chemotherapy Combined With Immunotherapy
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07496190Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Hai-Qiang Mai,MD,PhD · NCT06912698Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
Phase 3 · 1 location(s) · Lin Kong, MD · NCT06846450International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
Phase N/A · 1 location(s) · The University of Hong Kong-Shenzhen Hospital · NCT07013461Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
Phase 3 · 16 location(s) · Sun Yat-sen University · NCT07311772QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
Phase 3 · 19 location(s) · Sun Yat-Sen University Cancer Center · NCT06749899Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal C
Phase 2 · 4 location(s) · Sun Yat-sen University · NCT07362979Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whol
Phase N/A · 2 location(s) · Sun Yat-sen University · NCT06831357
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.